Regulation of IL (Interleukin)-33 Production in Endothelial Cells via Kinase Activation and Fas/CD95 Upregulation.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 11 9 2020
medline: 15 12 2020
entrez: 10 9 2020
Statut: ppublish

Résumé

The occurrence of new blood vessel formation in the lungs of asthmatic patients suggests a critical role for airway endothelial cells (ECs) in the disease. IL-33 (Interleukin-33)-a cytokine abundantly expressed in human lung ECs-recently emerged as a key factor in the development of allergic diseases, including asthma. In the present study, we evaluated whether mouse and human ECs exposed to the common Herein, we described a new mechanism involved in the control of IL-33 production in lung ECs exposed to allergens.

Identifiants

pubmed: 32907372
doi: 10.1161/ATVBAHA.120.314832
doi:

Substances chimiques

Antigens, Dermatophagoides 0
FAS protein, human 0
Fas protein, mouse 0
IL33 protein, human 0
Il33 protein, mouse 0
Interleukin-33 0
fas Receptor 0
Phosphatidylinositol 3-Kinase EC 2.7.1.137
Proto-Oncogene Proteins c-akt EC 2.7.11.1
Casp8 protein, mouse EC 3.4.22.-
Caspase 8 EC 3.4.22.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2619-2631

Auteurs

Catherine Duez (C)

CNRS UMR 9017, Inserm U1019, CIIL-Center for Infection and Immunity of Lille (C.D., P.M., V.L., C.G.), CHU Lille, Institut Pasteur de Lille, University Lille, France.

Barbara Gross (B)

Inserm U1011-EGID (B.G.), CHU Lille, Institut Pasteur de Lille, University Lille, France.

Philippe Marquillies (P)

CNRS UMR 9017, Inserm U1019, CIIL-Center for Infection and Immunity of Lille (C.D., P.M., V.L., C.G.), CHU Lille, Institut Pasteur de Lille, University Lille, France.

Valérie Ledroit (V)

CNRS UMR 9017, Inserm U1019, CIIL-Center for Infection and Immunity of Lille (C.D., P.M., V.L., C.G.), CHU Lille, Institut Pasteur de Lille, University Lille, France.

Bernhard Ryffel (B)

Laboratory of Molecular and Experimental Immunology and Neurogenetics, CNRS UMR 7355, University of Orleans, France (B.R.).

Corine Glineur (C)

CNRS UMR 9017, Inserm U1019, CIIL-Center for Infection and Immunity of Lille (C.D., P.M., V.L., C.G.), CHU Lille, Institut Pasteur de Lille, University Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH